Lista de obras - Marc Laine - Dominio Público Uruguay

A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity.

artículo científico publicado en 2013

Antiplatelet properties of oral anticoagulants

scientific article published on 24 December 2014

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome.

artículo científico publicado en 2017

Assessing post-treatment platelet reactivity: a focus on patient selection and setting.

artículo científico publicado en 2013

Biological efficacy and clinical safety of a second 600 mg loading dose of clopidogrel in elderly patients with high on-treatment platelet reactivity: a pilot study

artículo científico publicado en 2012

Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction

artículo científico publicado en 2012

Bivalirudin during percutaneous coronary intervention in acute coronary syndromes

artículo científico publicado en 2018

COMparison of Platelet reactivity following prAsugrel and ticagrelor loading dose in ST-Segment elevation myocardial infarctION patients: The COMPASSION study

artículo científico publicado en 2014

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity

artículo científico publicado en 2017

Clinical Impact of Genetically Determined Platelet Reactivity ⬇️

artículo científico publicado el 13 de noviembre de 2012

Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes.

artículo científico publicado en 2015

Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation

artículo científico

Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation: comment

scientific article published on 22 May 2017

Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation

artículo científico publicado en 2017

Device-Related Thrombus After Left Atrial Appendage Occlusion With the Amulet Device

artículo científico publicado en 2018

Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial.

artículo científico publicado en 2018

Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients

artículo científico publicado en 2014

Great expectations

scientific article published on 31 January 2018

Impact of the time-to-treatment concept on the outcome of acute heart failure: A pilot study

artículo científico publicado en 2018

In dubious battle: bleeding versus ischemic events

artículo científico publicado en 2016

Low basal expression of A2A adenosine receptors and increase in adenosine plasma concentration are associated with positive exercise stress testing

artículo científico publicado en 2014

Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives.

artículo científico

Mechanical support in cardiogenic shock complicating acute coronary syndrome: ready for prime time?

artículo científico publicado en 2018

Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease

scientific article published on 20 September 2018

On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome

artículo científico publicado en 2020

Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.

artículo científico publicado en 2015

Parameters of complete blood count do not predict on-treatment platelet reactivity in acute coronary syndrome patients

artículo científico publicado en 2017

Personalized Antiplatelet Therapy: The Odyssey Continues.

artículo científico publicado en 2016

Platelet Reactivity: Back to the Future?

artículo científico publicado en 2017

Platelet Reactivity: Journey to the End of the Night.

artículo científico publicado en 2017

Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention.

artículo científico publicado en 2013

Platelet reactivity in patients receiving a maintenance dose of P2Y12-ADP receptor antagonists undergoing elective percutaneous coronary intervention.

artículo científico

Pleiotropic effects of ticagrelor: Myth or reality?

artículo científico publicado en 2016

Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes

artículo científico

Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.

artículo científico

Prehospital and in-hospital course of care for patients with acute heart failure: Features and impact on prognosis in "real life".

artículo científico

Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach

artículo científico publicado en 2017

Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel

artículo científico publicado en 2012

Research and Therapeutic Nihilisms in Chronic Kidney Disease.

artículo científico publicado en 2017

Simultaneous pulmonary vein cryoablation and cavotricuspid isthmus radiofrequency ablation in patients with combined atrial fibrillation and typical atrial flutter

artículo científico publicado en 2015

Tailoring Antiplatelet Therapy: A Step Toward Individualized Therapy to Improve Clinical Outcome? ⬇️

artículo científico publicado el 1 de enero de 2012

Tailoring antiplatelet therapy--insanity or good sense?

artículo científico publicado en 2013

The impact of the environment on diseases and drugs.

artículo científico publicado en 2013

The safety of cardiac resynchronization therapy pacemaker implantation in octogenarians: A monocentric experience ⬇️

artículo científico publicado el 24 de mayo de 2013

Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.

artículo científico publicado en 2013

Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study

scientific article published on 31 March 2015

Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study.

artículo científico publicado en 2013

Ticagrelor: the silence of the platelets

artículo científico publicado en 2013

Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis.

artículo científico publicado en 2016

To Have and Have Not: Intrinsic Platelet Hyperreactivity?

artículo científico publicado en 2018

Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.

artículo científico publicado en 2018

Ventricular Arrhythmia Occurrence and Compliance in Patients Treated With the Wearable Cardioverter Defibrillator Following Percutaneous Coronary Intervention

artículo científico publicado en 2017

Ventricular allorhythmia during infarct-related ventricular tachycardia

artículo científico publicado en 2012

With age comes wisdom: is this true for platelets?

artículo científico publicado en 2013

Lista de obras de Marc Laine

A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity.

Antiplatelet properties of oral anticoagulants

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome.

Assessing post-treatment platelet reactivity: a focus on patient selection and setting.

Biological efficacy and clinical safety of a second 600 mg loading dose of clopidogrel in elderly patients with high on-treatment platelet reactivity: a pilot study

Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction

Bivalirudin during percutaneous coronary intervention in acute coronary syndromes

COMparison of Platelet reactivity following prAsugrel and ticagrelor loading dose in ST-Segment elevation myocardial infarctION patients: The COMPASSION study

Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity

Clinical Impact of Genetically Determined Platelet Reactivity ⬇️

Comparison of Ticagrelor Versus Prasugrel to Prevent Periprocedural Myonecrosis in Acute Coronary Syndromes.

Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation

Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation: comment

Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation

Device-Related Thrombus After Left Atrial Appendage Occlusion With the Amulet Device

Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial.

Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients

Great expectations

Impact of the time-to-treatment concept on the outcome of acute heart failure: A pilot study

In dubious battle: bleeding versus ischemic events

Low basal expression of A2A adenosine receptors and increase in adenosine plasma concentration are associated with positive exercise stress testing

Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives.

Mechanical support in cardiogenic shock complicating acute coronary syndrome: ready for prime time?

Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease

On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome

Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.

Parameters of complete blood count do not predict on-treatment platelet reactivity in acute coronary syndrome patients

Personalized Antiplatelet Therapy: The Odyssey Continues.

Platelet Reactivity: Back to the Future?

Platelet Reactivity: Journey to the End of the Night.

Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Platelet reactivity in patients receiving a maintenance dose of P2Y12-ADP receptor antagonists undergoing elective percutaneous coronary intervention.

Pleiotropic effects of ticagrelor: Myth or reality?

Potential mechanism of acute stent thrombosis with bivalirudin following percutaneous coronary intervention in acute coronary syndromes

Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.

Prehospital and in-hospital course of care for patients with acute heart failure: Features and impact on prognosis in "real life".

Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach

Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel

Research and Therapeutic Nihilisms in Chronic Kidney Disease.

Simultaneous pulmonary vein cryoablation and cavotricuspid isthmus radiofrequency ablation in patients with combined atrial fibrillation and typical atrial flutter

Tailoring Antiplatelet Therapy: A Step Toward Individualized Therapy to Improve Clinical Outcome? ⬇️

Tailoring antiplatelet therapy--insanity or good sense?

The impact of the environment on diseases and drugs.

The safety of cardiac resynchronization therapy pacemaker implantation in octogenarians: A monocentric experience ⬇️

Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.

Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study

Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study.

Ticagrelor: the silence of the platelets

Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis.

To Have and Have Not: Intrinsic Platelet Hyperreactivity?

Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome.

Ventricular Arrhythmia Occurrence and Compliance in Patients Treated With the Wearable Cardioverter Defibrillator Following Percutaneous Coronary Intervention

Ventricular allorhythmia during infarct-related ventricular tachycardia

With age comes wisdom: is this true for platelets?